Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PLAVIX
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
- Clopidogrel for the Prevention of Exacerbations in Severe COPD
- Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions
- Ticagrelor vs. Clopidogrel in Post PCI Patients
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
- To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
- Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
- Predicting Stroke Risk in ICAD With Novel MRI
- Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
- Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
- Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
- Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia
- Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting Condition
- Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass
- Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
- Antiplatelet Therapy in Heart Transplantation
- Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
- Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI
- Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
- Cilostazol and Endothelial Progenitor Cell
- Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
- Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
- Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers
- Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization
- GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
- Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)
- Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
- Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants
- Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
- Chronic Kidney Disease (CKD) Platelet Study
- SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
- Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm
- Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
- Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
- Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- CES1 Carriers in the PAPI Study
- CES1 Crossover Trial of Clopidogrel and Ticagrelor
- Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
- Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
- Migraine Prophylaxis With Clopidogrel Trial
- Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction
- Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke
- Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
- Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
- Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI
- Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.
- Ticagrelor Versus Clopidogrel in Carotid Artery Stenting
- Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
- Patent Versus Generic Clopidogrel in Acute Coronary Syndrome
- The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
- Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
- Ticagrelor in Human Endotoxemia Response to Human Endotoxemia
- Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)
- The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment
- Targeting Platelets in Chronic HIV Infection
- COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
- Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
- Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects
- Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
- Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel
- Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
- Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI
- Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity
- Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)
- Plasma and Platelet microRNAs in Clopidogrel Low Response Patients
- Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization
- A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
- Dose-escalation, Repeated and Single Oral Dosing Study
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the H
- Ticagrelor and Peripheral Arterial Disease
- Genotype and Platelet Reactivity in Patients on Hemodialysis
- Efficacy of Long Term Plavix Therapy Post Angioplasty
- Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
- Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
- Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study
- A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
- Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
- Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia
- Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
- Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
- Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
- Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling
- Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
- Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
- Clopidogrel Bioequivalence Study in Healthy Subjects
- Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel
- Clopidogrel Resistance and Embolism in Carotid Artery Stenting
- Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
- Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
- Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS
- Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)
- Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?
- Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
- Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
- Cilostazol Stroke Prevention Study for Antiplatelet Combination
- Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
- Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
- OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
- Ticagrelor for PCI Post Thrombolysis
- Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
- Ranitidin Versus Omeprazole in Patients Taking Clopidogrel
- Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation
- Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
- Pharmacogenomics of Antiplatelet Response - I
- GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
- Efficacy and Safety Study of Ticagrelor
- Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy Bleeding
- Effect of Ticagrelor on Endothelial Function
- Edoxaban in Peripheral Arterial Disease
- Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
- The Elderly ACS II Trial
- Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
- Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
- Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
- Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin
- Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
- Tailored Antiplatelet Therapy Following PCI
- Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
- A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
- Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects
- Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
- PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants
- Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Clopidogrel Tablets Under Fed Condition
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Clopidogrel Tablets Under Fasting Conditions
- Residual Platelet Activity In Advanced Peripheral Artery Disease
- Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions
- Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions
- Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary Intervention
- A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers
- Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
- Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy
- Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding
- Platelet Function Analysis in Head Trauma: ASA/Plavix
- Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
- Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions
- Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions
- The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers
- Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
- Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting
- Comparative Bioavailability Study of Two Oral Formulations of Clopidogrel
- Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)
- Comparative Pharmacokinetics of YH14659
- To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects
- Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
- Clopidogrel and Aspirin Interaction Study-2
- Clopidogrel Pharmacogenetics (PGX) Bench to Bedside
- Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
- Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease
- Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI
- Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
- Investigation of the Athero-Protective Effects of Clopidogrel
- The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
- Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation
- Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
- Aspirin and Plavix Following Coronary Artery Bypass Grafting
- Comparison of Generic and Original Formulation of Clopidogrel
- Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer
- Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
- Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty
- Pilot Study on the Effect of High Clopidogrel Maintenance Dosing
- Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
- Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
- Clopidogrel/Aspirin Interaction Study
- Clopidogrel Pharmacogenomics Project
- ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
- Clopidogrel Proton-Pump Inhibitors Study
- Prasugrel/Clopidogrel Maintenance Dose Washout Study
- Platelet Reactivity in Stent Thrombosis Patients
- Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
- Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
- Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events
- Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
- A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
- Clopidogrel and Aspirin for the Treatment of Polycythemia Vera
- Ex Vivo Human Thrombosis Chamber Study
- Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
- Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
- Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism
- Comparative Study of Two Brands of Heparin Already on the Market
- Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation
- A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome
- Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty
- Safe, Effective, and More Tolerable 16 Tablets Colon Prep
- Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial
- Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease
- Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers
- A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI
- GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients
- Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.
- Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing
- Healthy Volunteer Study of Clopidogrel and Rifampicin
- Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
- Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
- Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
- Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg
- Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg
- Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function
- A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders
- Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation
- Pharmacodynamics of CGT 2168 Compared With Plavix®
- PACT (Platelet Activity After Clopidogrel Termination)
- Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents
- A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin
- Effect of Fluvastatin on Top of Clopidogrel and Aspirin in Patients After DES Implantation on Platelet Aggregation
- Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
- The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent
- Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation
- Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
- Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
- Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
- Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor
- A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
- Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis
- PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
- 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
- Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
Clinical trials list
click for details